Why is Transgene Biotek falling/rising?

As of 07-Jul, Transgene Biotek Ltd is experiencing a decline in its stock price, currently at 4.82, which reflects a decrease of 0.03 or 0.62%. The stock has underperformed its sector by 0.91% today and has seen a trend reversal after three consecutive days of gains. Despite this recent downturn, the stock has shown a positive return of 4.78% over the past week and a significant increase of 20.80% over the past month. However, year-to-date, the stock is down 29.43%, and over the past year, it has decreased by 45.41%. The stock's moving averages indicate that it is currently higher than the 5-day, 20-day, 50-day, and 100-day averages but lower than the 200-day average, suggesting mixed signals regarding its longer-term trend. Additionally, there has been a rise in investor participation, with a delivery volume increase of 9.7% compared to the 5-day average, indicating some interest despite the price drop.
In the broader market context, the Sensex has shown a slight decline of 0.20% over the past week, while Transgene Biotek's performance has outpaced this benchmark. However, the stock's year-to-date performance is significantly worse than the Sensex, which has gained 6.79% during the same period. This contrast highlights the challenges faced by Transgene Biotek in the current market environment, despite its recent short-term gains. Overall, while there are signs of increased trading activity and short-term recovery, the stock's long-term performance remains concerning, contributing to its current price decline.